Published September 10, 2022
| Version v2
Dataset
Open
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease
Authors/Creators
- 1. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA; Department of Integrative Medicine, Huashan Hospital; Institutes of Integrative Medicine, Fudan University, Shanghai, China
- 2. Institute for Melanin Chemistry, Fujita Health University, Toyoake, Japan
- 3. Institute of Biomedical Technologies, National Research Council of Italy, Segrate (Milan), Italy
- 4. Department of Integrative Medicine, Huashan Hospital; Institutes of Integrative Medicine, Fudan University, Shanghai, China
- 5. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, USA
- 6. Department of Medical Technology, School of Health Sciences, Gifu University of Medical Science, Ichihiraga, Japan
- 7. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
- 8. Department of Chemistry, University of Pavia, Pavia, Italy
Description
Raw data sets for the manuscript "DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease"